Erratum: The neural correlates of social anxiety disorder and response to pharmacotherapy (Neuropsychopharmacology (2006) 31 (2243-2253) DOI: 10.1038/sj.npp.1301053);The neural correlates of social anxiety disorder and response to pharmacotherapy

Neuropsychopharmacology

Volumn 31, Issue 10, 2006, Pages 2243-2253

  Kilts, Clinton D ^a,b   Kelsey, Jeffrey E ^a   Knight, Bettina ^a   Ely, Timothy D ^a   Bowman, F DuBois ^c   Gross, Robin E ^a   Selvig, Amy ^a   Gordon, Angelita ^c   Newport, D Jeffrey ^a   Nemeroff, Charles B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

Amygdala; Nefazodone; Positron emission tomography (PET); Regional cerebral blood flow (rCBF); Social anxiety disorder; Social phobia

Indexed keywords

GALLIUM 68; GERMANIUM; NEFAZODONE; OXYGEN 15;

ADULT; ARITHMETIC; ARTICLE; BRAIN BLOOD FLOW; BRAIN REGION; CEREBELLUM; CINGULATE GYRUS; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS; IMAGERY; INSULA; MALE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; REMISSION; SELF CONCEPT; SOCIAL DISABILITY; SOCIAL PHOBIA; STATISTICAL ANALYSIS; TASK PERFORMANCE; THALAMUS; VOLUNTEER; WORK DISABILITY;

EID: 33748760065     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301205     Document Type: Erratum

References (66)

1. Abbott MJ, Rapee RM (2004). Post-event rumination and self-appraisal in social phobia before and after treatment. J Abnorm Psychol 113: 136-144.
2. Adolphs R (2001). The neurobiology of social cognition. Curr Opin Neurobiol 11: 231-239.
3. Baker KB, Kim JJ (2004). Amygdalar lateralization in fear conditioning: evidence for greater involvement of the right amygdala. Behav Neurosci 118: 15-23.
4. Bell CJ, Malizia AL, Nutt DJ (1999). The neurobiology of social phobia. Eur Arch Psychiatr Clin Neurosci 249: S11-S18.
5. Birbaumer N, Grodd W, Diedrich O, Klose U, Erb M, Lotze M et al (1998). fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 9: 1223-1226.
6. Bishop S, Duncan J, Brett M, Lawrence AD (2004). Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat Neurosci 7: 184-188.
7. Botvinick M, Braver TS, Carter CS, Cohen JD (2001). Conflict monitoring and cognitive control. Psychol Rev 108: 624-652.
8. Bourne EJ (1995). The Anxiety and Phobia Workbook, 2nd edn. New Harbinger Publications, Inc.: Oakland, CA.
9. Bowman D, Kilts CD (2003). Modeling intra-subject correlation among repeated scans in positron emission tomography (PET) neuroimaging data. Hum Brain Mapp 20: 59-70.
10. Breiter HC, Rauch SL, Kwong KK, Baker JR, Weisskoff RM, Kennedy DN et al (1996). Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatr 53: 595-606.
11. Britton JC, Phan KL, Taylor SF, Fig LM, Liberzon I (2005). Corticolimbic blood flow in posttraumatic stress disorder during script-driven imagery. Biol Psychiatr 57: 832-840.
12. Brothers L (1990). The social brain: a project for integrating primate behavior and neurophysiology in a new domain. Concepts Neurosci 1: 27-51.
13. Chartier MJ, Hazen AL, Stein MB (1998). Lifetime patterns of social phobia: a retrospective study of the course of social phobia in a nonclinical population. Depression Anxiety 7: 113-121.
14. Condren RM, O'Neill A, Ryan MCM, Barrett P, Thakore JH (2002). HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinol 27: 693-703.
15. Cox BJ, Fleet C, Stein MB (2004). Self-criticism and social phobia in the US national comorbidity survey. J Affect Disord 82: 227-234.
16. Davidson JT, Hughes DL, Georges LK (1993). The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med 23: 709-718.
17. Davis R, Whittington X, Bryson HM (1997). Nefazodone-a review of its pharmacology and clinical efficacy in the management of major depression. Drugs 53: 608-636.
18. den Boer JA (1997). Social phobia: epidemiology, recognition, and treatment. BMJ 315: 796-800.
19. First MB, Spitzer RL, Robert L, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. American Psychiatric Press: Washington, DC.
20. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiotta A, Langstrom B et al (2002). Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy. Arch Gen Psychiatr 59: 425-433.
21. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S et al (2004). Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavioral therapy. Arch Gen Psychiatr 61: 34-41.
22. Hamilton M (1960). Diagnosis and rating scale for depression. Br J Psychiatr 3: 76-79.
23. Izquierdo A, Murray EA (2004). Combined unilateral lesions of the amygdala and orbital frontal cortex impair affective processing in rhesus monkeys. J Neurophysiol 91: 2023-2039.
24. Kalin NH, Shelton SE, Davidson RJ (2004). The role of the central nucleus of the amygdala in mediating fear and anxiety in the primate. J Neurosci 24: 5506-5515.
25. Katzelnick DJ, Kobak KA, DeLeire T, Henk HJ, Greist JH, Davidson J et al (2001). Impact of generalized social anxiety disorder in managed care. Am J Psychiatr 158: 1999-2007.
26. Kelley WM, Macrae CN, Wyland CL, Caglar S, Inati S, Heatherton TF (2002). Finding the self: An event-related fMRI study. J Cognit Neurosci 14: 785-794.
27. Kessler RC, Berglund P, Demler O, Jin R, Walters EE (2005a). Lifetime prevalence and age-on-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatr 62: 593-602.
28. Kessler RC, Chiu WT, Demler O, Walters EE (2005b). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatr 62: 617-627.
29. Kessler RC, Stein MB, Berglund PA (1998). Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatr 155: 613-619.
30. Kimbrell TA, George MS, Parekh PI, Ketter TA, Podell DM, Danielson AL et al (1999). Regional brain activity during transient self-induced anxiety and anger in healthy adults. Biol Psychiatr 46: 454-465.
31. Kirschbaum C, Pirke KM, Hellhammer DH (1993). The Trier Social Stress Test: a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychoendocrinology 28: 76-81.
32. Liebowitz MR (1987). Social phobia. In: Klein DF (ed). Modern Problems in Pharmacopsychiatry: Anxiety, Vol. 22. Karger: Basel, NY. pp 141-173.
33. Liebowitz MR, Gorman JM, Fyer AJ, Klein DF (1985). Social phobia: review of a neglected anxiety disorder. Arch Gen Psychiatr 42: 729-736.
34. Mataix-Cols D, Cullen S, Lange K, Zelaya F, Andrew C, Amaro E et al (2003). Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers. Biol Psychiatr 53: 482-493.
35. Mathew SJ, Coplan JD, Gorman JM (2001). Neurobiological mechanisms of social anxiety disorder. Am J Psychiatr 158: 1558-1567.
36. Matsubara M, Yamaguchi S, Xu J, Kobayashi S (2004). Neural correlates for the suppression of habitual behavior: a functional MRI study. J Cogn Neurosci 16: 944-954.
37. Mayberg HS, Branna SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S et al (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatr 48: 830-843.
38. Mazziotta JC, Huang SC, Phelps ME (1985). A noninvasive positron computed tomography technique using oxygen-15-labeled water for the evaluation of neurobehavioral task batteries. J Cereb Blood Flow Metab 5: 70-78.
39. Miller EK, Cohen JD (2001). An integrative theory of prefrontal cortex function. Ann Rev Neurosci 24: 167-202.
40. Neter J, Kutner MH, Nachtsheim CJ, Wasserman W (1996). Applied Linear Statistical Models, 4th edn. McGraw Hill/Irwin: Chicago, IL.
41. Ochsner KN, Bunge SA, Gross JJ, Gabrieli JDE (2002). Rethinking feelings: an fMRI study of the cognitive regulation of emotion. J Cogn Neurosci 14: 1215-1229.
42. Ochsner KN, Ray RD, Cooper JC, Robertson ER, Chopra S, Gabrieli JDE et al (2004). For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. NeuroImage 23: 483-499.
43. Pitman RK, Orr SP, Forgue DF, de Jong JB, Claiborn JM (1987). Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam combat veterans. Arch Gen Psychiatry 44: 970-975.
44. Rapee RM, Heimberg RG (1997). A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther 35: 741-756.
45. Rauch SL, Savage CR, Alpert NM, Miguel EC, Baer L, Breiter HC et al (1995). A positron emission tomography study of simple phobic symptom provocation. Arch Gen Psychiatr 52: 20-28.
46. Safren SA, Heimberg RG, Brown EJ, Holle C (1997). Quality of life in social phobia. Anxiety 4: 126-133.
47. Saxena S, Brody AL, Maidment KM, Dunkin JJ, Colgan M, Alborzian S et al (1999). Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology 21: 683-693.
48. Schneider F, Weiss U, Kessler C, Müler-Gärtner HW, Poss S, Salloum JB et al (1999). Subcortical correlates of differential classical conditioning of aversive emotional reactions in social phobia. Biol Psychiatr 45: 863-871.
49. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A et al (1994). Functional impairment in social phobia. J Clin Psychiatr 55: 322-331.
50. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM (1992). Social phobia: comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatr 49: 282-288.
51. Schneier FR, Liebowitz MR, Abi-Dargham A, Zea-Ponce Y, Lin SH, Laruelle M (2000). Low dopamine D2 receptor binding potential in social phobia. Am J Psychiatr 157: 457-459.
52. Sheehan PQ (1967). A shortened form of Bett's questionnaire on mental imagery. J Clin Psychol 223: 380-389.
53. Shin LM, McNally RJ, Kosslyn SM, Thompson WL, Rauch SL, Alpert NM et al (1999). Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related PTSD: a PET investigation. Am J Psychiatr 156: 575-584.
54. Stein MB, Goldin PR, Sareen J, Zorrilla L, Brown GG (2002). Increased amygdala activation to angry and contempuous faces in generalized social phobia. Arch Gen Psychiatr 59: 1027-1034.
55. Stein MB, Kean YM (2000). Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatr 157: 1606-1613.
56. Stein MB, Walker JR, Forde DR (1996). Public speaking fears in a community sample: prevalence, impact on functioning, and diagnostic classification. Arch Gen Psychiatr 53: 169-174.
57. Straube T, Glauer M, Dilger S, Mentzel HJ, Miltner WHR (2006). Effects of cognitive-behavioral therapy on brain activation in specific phobia. NeuroImage 29: 125-135.
58. Talairach J, Tournoux P (1988). Co-Planar Stereotaxic Atlas of the Human Brain. Thieme Medical Publishers: New York. 122pp.
59. Tiihonen J, Kuikka J, Bergstrom K, Lepola U, Koponen H, Leinonen E (1997). Dopamine reuptake site densities in patients with social phobia. Am J Psychiatr 154: 239-242.
60. Tillfors M, Furmark T, Marteinsdottir I, Fredrickson M (2002). Cerebral blood flow during anticipation of public speaking in social phobia: a PET study. Biol Psychiatr 52: 1113-1119.
61. Tillfors M, Furmark T, Marteinsdottir I, Fischer H, Pissiota A, Landstrom B et al (2001). Cerebral Blood Flow in Subjects With Social Phobia During Stressful Speaking Tasks: A PET Study. Am J Psychiatr 158: 1220-1226.
62. Verbeke G, Molenberghs G (2000). Linear Mixed Models for Longitudinal Data. Springer: New York.
63. Weiller E, Bisserbe JC, Boyer P, Lepine JP, Lecrubier Y (1996). Social phobia in general health care: an unrecognised undertreated disabling disorder. Br J Psychiatr 168: 169-174.
64. Wittchen HU, Fuetsch M, Sonntag H, Muller N, Liebowitz M (2000). Disability and quality of life in pure and comorbid social phobia. Findings from a controlled study. Eur Psychiatr 15: 46-58.
65. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC (1998a). Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr 22: 139-152.
66. Woods RP, Grafton ST, Watson JDG, Sicotte NL, Mazziotta JC (1998b). Automated image registration: II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr 22: 53-165.